Abstract
BackgroundData on infections in patients exposed to biological therapies are mainly focused on rheumatoid arthritis (RA). Little is known about the safety profile in other chronic inflammatory immune-mediated diseases (CIID).ObjectivesTo...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
